This is craziness.
So you would think, should there be a cheap, effective, and low impact method of killing cancer cells, the world would rejoice, right?
Scientists at the University of Alberta in Edmonton have discovered that a cheap drug used to treat metabolic disorders has the ability-- not the potential, but the ability-- to activate mitochondria in the fight against mutated cancer cells, killing the cells while leaving healthy cells alone.
"In human bodies there is a natural cancer fighting human cell, the mitochondria, but they need to be triggered to be effective. Scientists used to think that these mitochondria cells were damaged and thus ineffective against cancer. So they used to focus on glycolysis, which is less effective in curing cancer and more wasteful. The drug manufacturers focused on this glycolysis method to fight cancer. This DCA on the other hand doesn’t rely on glycolysis instead on mitochondria; it triggers the mitochondria which in turn fights the cancer cells."
So why aren't pharmaceutical companies trumpeting this new "cure" for cancer? Easy. It doesn't require a patent. It's a cheap drug, and therefore less profitable. Heaven forbid that the most profitable industry on Earth actually start marketing cheaper and healthier methods of defeating the leading killer disease of just about every demographic.
Thanks to Wesley Darling for the tip.
UPDATE: OAQ's readers have been the subject of a bit of misinformation. Click here.